Antrum R M, Bibby S R, Ramsden C H, Kester R C
Department of Vascular Surgery, St. James's University Hospital, Leeds, UK.
Drugs Exp Clin Res. 1989;15(1):25-7.
Teicoplanin is a new antibiotic currently undergoing extensive investigation to evaluate its potential use in the prophylaxis and treatment of appropriate infection. To ascertain its penetration into the biliary system, 24 patients undergoing elective cholecystectomy were randomised to receive an intravenous bolus of 400 mg teicoplanin 1, 3, 6 or 12 h prior to surgery. During the operation, blood, gall bladder bile and tissue and common bile duct bile were removed for teicoplanin estimation. The results show that teicoplanin penetrates well into the gall bladder wall and bile, though less well into common bile duct bile. These results show that teicoplanin would seem to be a suitable antibiotic for the treatment of biliary infections that are known to be sensitive to the antibiotic.
替考拉宁是一种新型抗生素,目前正在进行广泛研究,以评估其在预防和治疗相关感染方面的潜在用途。为确定其在胆道系统中的渗透情况,24例行择期胆囊切除术的患者被随机分组,于手术前1、3、6或12小时接受400mg替考拉宁静脉推注。手术过程中,采集血液、胆囊胆汁、组织及胆总管胆汁用于替考拉宁含量测定。结果显示,替考拉宁能很好地渗透至胆囊壁和胆汁中,不过在胆总管胆汁中的渗透效果稍差。这些结果表明,替考拉宁似乎是治疗已知对该抗生素敏感的胆道感染的合适抗生素。